National Institute Of Allergy And Infectious Diseases

The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine. Read More

New research offers hope for patients needing the anti-inflammatory benefits of glucocorticoids without the adverse side effects associated with them. Read More